Apligraf: Difference between revisions

Line 1:

Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFwebQuote

| quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins

| last=

| first=

| publisher=Organogenesis

| year=

| urltitle=Apligraf: How Is It Made?

| url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/

| accessdate=2011-03-06

}}</ref> It is [[FDA]] approved,<ref>{{REFwebQuote

| quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).

| last=

| first=

| publisher=Organogenesis

| year=

| urltitle=Apligraf

| url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html

| accessdate=2011-03-06

}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

~~[[Image:Alloderm-logo.jpg|right|thumb|]]~~

== Apligraph Oral ==

~~Apligraf is a synthetic skin created from harvested foreskins.<ref>~~

~~{{cite web~~

~~| url~~ = ~~http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/~~

~~| title~~ = ~~Apligraf: How Is It Made?~~

~~| accessdate~~ = ~~2011-03-06~~

~~| publisher~~ = ~~Organogenesis~~

~~| quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins~~

}}

~~</ref> It is [[FDA]] approved,<ref>~~

~~{{cite web~~

~~| url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html~~

~~| title = Apligraf~~

~~| accessdate = 2011-03-06~~

~~| publisher = Organogenesis~~

~~| quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).~~

}}

~~</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.~~

~~==Apligraph Oral==~~

Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews

| last=

Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{~~cite web~~ | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | accessdate = 2011-12-20 ~~| date = November 2011~~}}</ref>

| first=

| coauthors=

| url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf

| title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript

| date=November 2011

| publisher=FDA

| quote=

| accessdate=2011-12-20

}}</ref>

Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf

~~==<small>References</small>==~~

~~<div class='references-small'>~~

~~<references/>~~

~~</div>~~

[[Category:Foreskin Products]]

@@ Line 1: / Line 1: @@
-{{Construction Site}}
+<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->
+Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFwebQuote
+ | quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins
+ | last=
+ | first=
+ | publisher=Organogenesis
+ | year=
+ | urltitle=Apligraf: How Is It Made?
+ | url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
+ | accessdate=2011-03-06
+}}</ref> It is [[FDA]] approved,<ref>{{REFwebQuote
+ | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
+ | last=
+ | first=
+ | publisher=Organogenesis
+ | year=
+ | urltitle=Apligraf
+ | url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
+ | accessdate=2011-03-06
+}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
-[[Image:Alloderm-logo.jpg|right|thumb|]]
+== Apligraph Oral ==
-Apligraf is a synthetic skin created from harvested foreskins.<ref>
-{{cite web
- | url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
- | title = Apligraf: How Is It Made?
- | accessdate = 2011-03-06
- | publisher = Organogenesis
- | quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins
-}}
-</ref> It is [[FDA]] approved,<ref>
-{{cite web
- | url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
- | title = Apligraf
- | accessdate = 2011-03-06
- | publisher = Organogenesis
- | quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
-}}
-</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
-==Apligraph Oral==
+Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
+ | last=
-Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | accessdate = 2011-12-20 | date = November 2011}}</ref>
+ | first=
+ | coauthors=
+ | url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
+ | title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
+ | date=November 2011
+ | publisher=FDA
+ | quote=
+ | accessdate=2011-12-20
+}}</ref>
 Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
-==<small>References</small>==
+{{REF}}
-<div class='references-small'>
-<references/>
-</div>
 [[Category:Foreskin Products]]